New late-breaking data presented at ESC Congress 2026 adds to the growing evidence that more invasive catheter-based pulmonary embolism procedures can improve patient outcomes.

While T-TEER is already known to improve a patient's quality of life, this late-breaking study from ESC Congress 2026 confirmed it also improves survival and reduces the risk of heart failure hospitalization.

AI technology developed by Caristo Diagnostics was the focus of multiple studies presented at ESC Congress 2026.

It was a relatively small study, and patients were only followed for six months, but these late-breaking data out of ESC Congress 2026 give care teams a lot to consider. 

“Our findings do not support routine electrical mapping to target left ventricular lead placement in contemporary CRT practice,” one researcher said. 

Many patients who need TAVR also present with coronary artery disease. According to new data presented at ESC Congress 2026, performing TAVR first is noninferior to performing PCI first. 

New data presented at ESC Congress 2026 represent a huge breakthrough for patients with nonobstructive HCM. "For the first time, we have shown clinically meaningful improvements in symptoms and exercise capacity with a treatment that targets the cause of the disease," one researcher explained. 

AI-powered software from Heartflow can provide cath labs with a lot of value, according to new late-breaking data presented at ESC Congress 2026.